The study found that the number of advanced therapy Phase I trials in the UK nearly doubled since the same time in 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback